S. S. Trasi and N. Sashidharan, “Itolizumab as the First Line of Treatment in Moderate to Severe Chronic Plaque Psoriasis- A Case Report”, Asian J Pharm Clin Res, vol. 9, no. 2, p. 12, Mar. 2016.